Le Lézard
Classified in: Health
Subject: SHM

HLS Therapeutics Reports Annual Meeting Results


TORONTO, June 17, 2022 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on central nervous system and cardiovascular markets, announces voting results from its Annual Meeting of Shareholders held in a virtual format on June 17, 2022.

A total of 23,394,920 Common Shares, or 72.06% of the total Common Shares issued and outstanding, were voted based on proxies and votes received at the meeting. Details of the voting by individual director were as follows:

 

Name of Nominee

Votes Cast
FOR

% of Vote Cast
FOR

Votes
WITHHELD

% of Votes
WITHHELD

Gilbert Godin

20,753,293

99.75

51,396

0.25

Greg Gubitz

20,712,831

99.75

51,432

0.25

J. Spencer Lanthier

20,662,746

99.51

101,517

0.49

Yvon Bastien

19,646,377

94.62

1,117,886

5.38

Rodney Hill

20,518,531

98.82

245,732

1.18

Don DeGolyer

17,454,248

84.09

3,310,015

15.94

Laura Brege

19,567,322

94.24

1,196,941

5.76

John Welborn

20,524,460

98.85

239,803

1.15

Norma Beauchamp

19,634,591

94.56

1,129,672

5.44

 

HLS also confirms that shareholders approved the appointment of Ernst & Young LLP as the Company's auditors with 23,201,466, or 99.18%, of the votes in favour and 191,954, or 0.82%, of the votes withheld.

ABOUT HLS THERAPEUTICS INC.
Formed in 2015, HLS is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. HLS's focus is on products targeting the central nervous system and cardiovascular therapeutic areas. HLS's management team is composed of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages. For more information visit: www.hlstherapeutics.com.

SOURCE HLS Therapeutics Inc.


These press releases may also interest you

at 12:15
ResBiotic Nutrition, Inc. (ResBiotic), the pioneering physician-developed pre/probiotic wellness scale-up, proudly announces the appointments of Stefany Nieto as Vice President of Operations and Brittany Zenner as Director of Marketing. Nieto is a...

at 12:06
Maid Sailors Cleaning Service has joined forces with Cleaning for a Reason, a non-profit organization offering free house cleaning services to cancer patients across the United States and Canada....

at 12:05
Terragia Biofuel, a technology startup aiming to drive the next generation of biofuels, today announced it has raised a $6 million seed round led by Engine Ventures and Energy Impact Partners (EIP). The company will use the capital to commercialize...

at 12:05
Float, the marketplace moving all the care that doesn't need a hospital to the home, today announced $10 million in Series A funding led by Canvas Ventures, whose General Partner Mike Ghaffary has joined Float's board, with participation from Wave...

at 12:00
V-Wave today announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American College of Cardiology's (ACC) Annual Scientific Session & Expo taking place April 6-8 in Atlanta. RELIEVE-HF is a randomized, double-blind,...

at 12:00
Critical Path Institute's (C-Path) Duchenne Regulatory Science Consortium (D-RSC) is excited to announce the launch of a groundbreaking model-based Clinical Trial Simulator (CTS), specifically designed to improve design of efficacy studies for...



News published on and distributed by: